share_log

恒瑞医药(600276.SH):筹划发行H股股票并上市相关事项

Jiangsu Hengrui Pharmaceuticals (600276.SH): Planning to issue H shares stocks and related listing matters.

Gelonghui Finance ·  Dec 9 04:50

Gelonghui, December 9 | Hengrui Pharmaceutical (600276.SH) announced that in order to further promote technological innovation and an international two-wheel drive strategy and further help the development of the company's international business, the company plans to issue shares (H shares) overseas and list them on the main board of the Hong Kong Stock Exchange Limited (“Hong Kong Stock Exchange”). The company will fully consider the interests of existing shareholders and the situation in domestic and foreign capital markets, and select an appropriate timing and issuance window to complete the issuance and listing within the validity period of the shareholders' meeting resolution (that is, 18 months from the date of review and approval by the company's shareholders' meeting or other period agreed to be extended).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment